Q32 Bio (QTTB) Operating Leases (2020 - 2026)

Q32 Bio has reported Operating Leases for 7 years, with the latest figure at $4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 13.04% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (down 13.04% YoY), and the FY2025 full-year result was $4.9 million, down 12.3% from the prior year.
• Operating Leases for Q1 2026 stood at $4.8 million, down from $4.9 million in the prior quarter.
• The five-year high for Operating Leases was $28.3 million in Q3 2022, with the low at $4.8 million in Q1 2026.
• Average Operating Leases over 5 years is $14.1 million, with a median of $6.1 million recorded in 2024.
• Year-over-year, Operating Leases jumped 144.67% in 2022 and plunged 78.19% in 2024.
• Tracing QTTB's Operating Leases over 5 years: stood at $27.9 million in 2022, then plunged by 77.62% to $6.2 million in 2023, then retreated by 9.8% to $5.6 million in 2024, then decreased by 12.3% to $4.9 million in 2025, then declined by 3.82% to $4.8 million in 2026.
• The last three Operating Leases figures came in at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison